BioLegend is a global leader in the supply of antibodies and reagents for biomedical research. Since its inception in 2002, the firm has evolved to become a leading brand in the life sciences market, producing novel technologies that allow breakthroughs in immunology, cancer, neurology, stem cell biology, and other fields. BioLegend offers a diverse range of antibodies, recombinant proteins, ELISA kits, flow cytometry reagents, and other research tools.
The firm is dedicated to quality, providing items that have been extensively tested and certified, as well as providing great customer service. The objective of BioLegend is to improve scientific research and speed the development of innovative medicines and cures for human ailments. Customers in academic, pharmaceutical, biotech, and clinical research institutions across the world are served by the company's global distribution network.